Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial

BACKGROUND: Cytomegalovirus (CMV) prophylaxis may prevent CMV indirect effects in renal transplant recipients. This study aimed to compare the efficacy of valganciclovir and valacyclovir prophylaxis for CMV after renal transplantation with the focus on chronic histologic damage within the graft. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Reischig, Tomas, Kacer, Martin, Hruba, Petra, Hermanova, Hana, Hes, Ondrej, Lysak, Daniel, Kormunda, Stanislav, Bouda, Mirko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238264/
https://www.ncbi.nlm.nih.gov/pubmed/30442095
http://dx.doi.org/10.1186/s12879-018-3493-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238264/
https://www.ncbi.nlm.nih.gov/pubmed/30442095
http://dx.doi.org/10.1186/s12879-018-3493-y

Ejemplares similares